In an array of non-Hodgkin lymphoma (NHL) subsets, CD47 was found to be increased on primary NHL cells compared to B cells, which was an independent predictor for worse clinical outcomes [33]. This evidence concerns the gene CD47 and non-Hodgkin lymphoma.